glp 1 and cannabinoids Molecular docking of danuglipron uncovers potential crossovers between GLP- 1R the endocannabinoid system Antidiabetic actions of GPR55 agonist

Findings of NAD and glutathione changes are reported in genetic metabolic diseases as well as in degenerative, age-related diseases 1,2

Fetlock swelling can be serious when it appears with heat, pain, lameness, or reluctance to bear weight

The link between the endocannabinoid system and body weight regulation was the foundation for the development of the cannabinoid CB1 receptor inverse agonist rimonabant as an effective medication in promoting weight loss in people with obesity

For liver health, a Phase 2a trial in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) showed extraordinary results